Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Sch 1 Update - ISIS Resources

15 Sep 2006 11:23

AIM15 September 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME: Verona Pharma plc (previously Isis Resources plc) COMPANY ADDRESS: Adderbury Hill Barn, Milton Road, Adderbury, Oxon COMPANY POSTCODE: OX17 3HN COUNTRY OF INCORPORATION: United Kingdom COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES: The company is involved in drug discovery focused on the discovery and development of new therapeutic drugs for thetreatment of allergic rhinitis (hay fever) and other chronic respiratory and inflammatory diseases. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which itseeks admission and the number and type to be held as treasury shares): 144,275,000 Ordinary Shares of £0.001 each CAPITAL TO BE RAISED ON ADMISSION: £2.043 million FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Professor Clive Peter Page, Non-Executive Chairman Professor Michael John Alfred Walker, Chief Executive Officer Claire Louise Poll, Executive Director Professor Trevor Mervyn Jones, Non-Executive Director Herbert Stuart Bottomley, Non-Executive Director PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION: Prior to Admission %Craig Burton* 19.9Pershing Keen Nominees Ltd** 18.5Williams de Broe 7.0Stuart Bottomley*** 7.0Josef El Raghy 6.0Fitel Nominees Ltd a/c CO57658 5.6Jamie Boyton 4.8William Fairweather 4.6Fitel Nominees Ltd a/c CO58142 4.2Mark Freeman 4.0Tolle Investments Pty Ltd 4.0 * Mr. Burton's interests are held through the CI Burton Family Trust A/C and CI Burton Super Fund A/C ** Pershing Keen Nominees Ltd holds an additional 3,000,000 ordinary shares on behalf o f Josef El Raghy, a director of the Company *** Mr. Bottomley's interests are held through The Bank of New York (Nominees) Limited After admission %Fidelity Euro Smaller Companies Fund 9.70Craig Burton* 8.66Pershing Keen Nominees Ltd** 6.42Williams de Broe 5.80Stuart Bottomley*** 4.16Clive Page 3.92Michael Walker 3.91David Saint 3.91Millenium Capital Partners 3.19* Mr. Burton's interests are held through the CI Burton Family Trust A/C and CI Burton Super Fund A /C ** Pershing Keen Nominees Ltd holds an additional 3,000,000 ordinary shares on behalf o f Josef El Raghy, a director of the Company *** Mr. Bottomley's interests are held through The Bank of New York (Nominees) Limited NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES: None ANTICIPATED ACCOUNTING REFERENCE DATE: 31 December EXPECTED ADMISSION DATE: 19 September 2006 NAME AND ADDRESS OF NOMINATED ADVISER: Hanson Westhouse LLP 12th Floor One Angel Court London EC2R 7HJ NAME AND ADDRESS OF BROKER: Hanson Westhouse LLP 12th Floor One Angel Court London EC2R 7HJ DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THISWILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: Hanson Westhouse LLP 12th Floor One Angel Court London EC2R 7HJ DATE OF NOTIFICATION:15 September 2006UPDATE Update This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20094:21 pmPRNIssue of Equity
31st Mar 20094:11 pmPRNNotice of Interest in the Company
25th Mar 20097:00 amPRN2008 Preliminary Unaudited Results
28th Jan 20097:00 amPRNApproval to Start Clinical Trials
9th Jan 20092:13 pmRNSHolding(s) in Company
11th Nov 20084:47 pmRNSHolding(s) in Company
23rd Sep 20087:00 amPRNHalf-yearly Report
9th Sep 20087:00 amPRNUpdate on Clinical Trials
31st Jul 20087:00 amPRNTotal Voting Rights
7th Jul 20085:10 pmPRNIssue of Equity
23rd May 20084:36 pmRNSResult of AGM
19th May 20087:00 amPRNPlanned asthma and hay fever drug passes crucial tests
14th May 20087:00 amPRNIssue of Equity
30th Apr 20089:18 amRNSIssue of Equity
2nd Apr 20087:00 amPRN2007 Preliminary Financial Results
19th Mar 20081:26 pmPRNChange of Registered Office
26th Feb 20087:00 amPRNProgress Update
31st Jan 20087:00 amPRNTotal Voting Rights Update
17th Jan 20081:27 pmPRNNotification of Interest
11th Jan 20087:00 amPRNNotification of Interest
9th Jan 200812:44 pmPRNNotification of Interest
7th Jan 200812:06 pmPRNResult of General Meeting & Directors' Holdings
31st Dec 20077:00 amRNSTotal Voting Rights
31st Dec 20077:00 amPRNTotal Voting Rights in Company
17th Dec 20077:00 amPRNProposed Placing and Notice of General Meeting
10th Dec 200712:07 pmPRNIssue of Equity
13th Nov 20077:00 amPRNVerona Pharma seeks drug treatment for coughing
6th Nov 20072:47 pmPRNVerona Pharma Progresses Anti-Asthma Drug Studies
4th Oct 20077:00 amPRNVerona Pharma launches regulatory studies for RPL554
10th Sep 20074:21 pmPRNInterim Report For The Six Months Ended 30 June 2007
16th Aug 20075:07 pmPRNHolding(s) in Company
1st Aug 20071:44 pmPRNNotification of Website Address
2nd Jul 20073:23 pmPRNDirector Shareholding
25th Jun 200711:09 amPRNDirector Shareholding
29th May 200712:11 pmPRNCommencement of RPL554 Preclinical Studies
9th May 200710:43 amRNSApptmnt of Nomad & Broker
26th Apr 20077:01 amRNSFinal Results
20th Mar 20077:00 amPRNAgreement with HepMim Biosciences
5th Feb 20075:58 pmPRNDirector/PDMR Shareholding
22nd Jan 20077:00 amPRNRPL554 Update
15th Dec 200612:43 pmPRNTotal Voting Rights
15th Dec 20067:00 amPRNUPDATE ON NAIPS PROGRAMME
27th Nov 20067:00 amPRNRPL554 Drug development project
2nd Oct 20061:09 pmRNSHolding(s) in Company
2nd Oct 200611:23 amRNSCompany Secretary Appointment
29th Sep 20069:28 amRNSInterim Results
19th Sep 20067:00 amRNSReadmission and name change
18th Sep 20068:57 amRNSResult of EGM
15th Sep 200611:23 amRNSSch 1 Update - ISIS Resources
1st Sep 200610:10 amRNSSch 1 - ISIS Resources PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.